@article{JTD32183,
author = {Fernando Franco and Mariano Provencio},
title = {Neoadjuvant treatment with tyrosine kinase inhibitors in patients with resectable non-small cell lung cancer},
journal = {Journal of Thoracic Disease},
volume = {11},
number = {10},
year = {2019},
keywords = {},
abstract = {We have carefully read the article written by Dr. Zhang et al. in which they reported your surgical experience in six patients with resectable epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC) after gefitinib as neoadjuvant therapy (1).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/32183}
}